Pages that link to "Q48241892"

The following pages link to Differential vulnerability of dopamine receptors in the mouse brain treated with MPTP. (Q48241892):

Displaying 12 items.

• Neuroprotective and anti-inflammatory activities of ketogenic diet on MPTP-induced neurotoxicity (Q43120302) (← links)
• Biochemical and immunohistological changes in the brain of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mouse (Q43511625) (← links)
• Riluzole (2-amino-6-trifluoromethoxy benzothiazole) attenuates MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice (Q43752100) (← links)
• Neuroprotective effect of riluzole in MPTP-treated mice (Q43782689) (← links)
• Therapeutic effect of neuronal nitric oxide synthase inhibitor (7-nitroindazole) against MPTP neurotoxicity in mice (Q44152190) (← links)
• Role of dopamine transporter against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice (Q44488554) (← links)
• Neuroprotective effect of the angiotensin-converting enzyme inhibitor perindopril in MPTP-treated mice (Q45029150) (← links)
• Quantitative 1H magnetic resonance spectroscopic imaging determines therapeutic immunization efficacy in an animal model of Parkinson's disease. (Q45269942) (← links)
• Neuropathological changes induced by neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in male Swiss albino mice (Q46325524) (← links)
• Striatal dopamine depletion and behavioural sensitization induced by methamphetamine and 3-nitropropionic acid (Q73318384) (← links)
• Dopamine Synthesis as a Mechanism of Brain Plasticity in Nigrostriatal System Pathology (Q88738898) (← links)
• Shared cerebral metabolic pathology in non-transgenic animal models of Alzheimer's and Parkinson's disease (Q89586522) (← links)